StockNews.com Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy

Phibro Animal Health (NASDAQ:PAHC) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday.

PAHC has been the topic of a number of other research reports. Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Finally, Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Stock Down 4.8 %

Shares of NASDAQ:PAHC traded down $1.07 during trading on Wednesday, reaching $21.27. 162,460 shares of the stock were exchanged, compared to its average volume of 157,644. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The stock has a fifty day moving average of $23.63 and a two-hundred day moving average of $20.66. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The firm has a market cap of $861.50 million, a price-to-earnings ratio of 49.47, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors and hedge funds have recently bought and sold shares of PAHC. CWM LLC lifted its holdings in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. nVerses Capital LLC bought a new stake in Phibro Animal Health during the third quarter valued at approximately $70,000. Quantbot Technologies LP purchased a new position in Phibro Animal Health in the 3rd quarter worth approximately $70,000. Summit Securities Group LLC bought a new position in shares of Phibro Animal Health in the 2nd quarter worth $83,000. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the last quarter. 99.34% of the stock is owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.